Cite
Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.
MLA
Chen, Jiaojiao, et al. “Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.” Pharmaceutics, vol. 14, no. 4, Apr. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/pharmaceutics14040842.
APA
Chen, J., Li, S., Wang, Q., Wang, C., Qiu, Y., Yang, L., Han, R., Du, Q., Chen, L., Dong, Y., & Wang, T. (2022). Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy. Pharmaceutics, 14(4), N.PAG. https://doi.org/10.3390/pharmaceutics14040842
Chicago
Chen, Jiaojiao, Sihan Li, Quanfang Wang, Chuhui Wang, Yulan Qiu, Luting Yang, Ruiying Han, et al. 2022. “Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.” Pharmaceutics 14 (4): N.PAG. doi:10.3390/pharmaceutics14040842.